A heavy duty but compact and light-weight haematology analyser, Abacus 3 80 offers an optimal solution for hospitals, clinics and practices that require high quality and rapid complete blood count results. The built-in thermal printer, the automatic cleaning and the multilingual operating menu and large colour LCD with touch screen interface make the instrument very user-friendly. Providing 20 parameters and a complete blood count including 3-part differential, the instrument provides a throughput of 80 tests per hour, with results available in 45 seconds.
Read more

Methicillin resistant Staphylococcus aureus (MRSA) infections are responsible for a high number of patient deaths in hospital settings and significantly contribute to health care costs. The reduction of healthcare-associated MRSA infections could potentially improve patient outcome and reduce the level of service, provided test results can be turned around in an adequate time and testing is cost effective. The Sentosa SA Direct MRSA/SA PCR test is a rapid PCR 4-plex assay for the simultaneous detection and differentiation of S. aureus Type I to VII and XI SCCmec/orf X cassettes including mecC. Test results are available after only 2.5 hours with minimum hands-on time due to automated reporting. Differential target detection reduces the number of false positive MRSA results caused by cassette “empty” mecA or S. epidermidis infections. The reliable and cost efficient Sentosa SA Direct MRSA/SA PCR test is well suited for today’s healthcare settings and an excellent alternative to culture methods or more cost-intensive PCR tests.

Read more

The second generation of the popular automated urinalysis system that combines a urine chemistry analyzer and a urine sediment analyzer is introduced. The LabUMat 2 is designed for high volume urine test strip reading and for analyzing three physical parameters. The UriSed 2 is able to detect urine particles in urine sediment with high accuracy. Relying on the automation of traditional manual microscopy and advanced image processing the sediment analyzer offers a unique method for sedimentation. It performs sample preparation, provides whole field of view microscopic images of sediment and identifies urine particles in a fully automated way, while human evaluation is also possible any time after the measurement on screen, without manual microscopy. The interfaced LabUMat 2 & UriSed 2 analyzers form a Complete Urine Laboratory System working without any special liquid reagents. This latest development of 77 Elektronika is a walk-away system dealing with the workload of big laboratories. The automated technology improves diagnostic quality by increased reproducibility and accuracy and also improves productivity by eliminating the time consuming procedure of manual sample preparation.  

More info – contact: sales@e77.hu
Read more

Although widely understood and recognised as a key marker in wound healing, currently elevated protease activity (EPA) in chronic wounds goes undetected as there are no visual cues for it. A recently published study showed that chronic wounds with EPA have a 90% probability that they will not heal without appropriate intervention. The estimated 30 million chronic wounds treated each year account for approximately 3% of total health expenditure. Until now, with almost 30% of non-healing wounds having EPA, the absence of a test could result in ineffective treatment choices, leading to significant cost to healthcare providers. Wound care clinicians’ calls for better diagnostic tools to aid wound assessment have now been answered with the CE marking of WOUNDCHECK Protease Status, the world’s first rapid, point-of-care diagnostic test developed specifically for chronic wounds. It has the potential to revolutionise wound care by enabling early, targeted intervention and cost-effective use of advanced therapies to modulate protease activity. Designed to form part of routine wound assessment, the test is easy-to-use and provides results in just 15 minutes at the point of care. This enables the test to immediately influence treatment decisions and help clinicians target advanced wound care therapies more effectively by identifying when EPA exists in chronic wounds. As the implementation of point-of-care testing is new to many wound care clinicians, there is a new online training tool for the training of prospective users.
Read more